Musculoskeletal Tumors Application of the Technique Stereotactic Body Radiotherapy (Sbrt), In Pulmonary Metastases of Sarcomatoso Origin, Review of Highlighted Literature_Crimson Publishers

Musculoskeletal Tumors Application of the Technique Stereotactic Body Radiotherapy (Sbrt), In Pulmonary Metastases of Sarcomatoso Origin, Review of Highlighted Literature by Mariana Perez De Antueno in Crimson Publishers: Journal of Cancer Research

 
Crimson Publishers_ Novel Approaches in Cancer Study

Stereotactic body radiotherapy (SBRT) is a radiotherapy technique that provides radiation from many different positions around the body. The rays are focused on the tumor, with this we achieve that the lesion receives a high dose of radiation and the tissues around it receive a low dose, thus reducing the risk of side effects. It is applied between 1 and 5 sessions, and therefore it is possible to reduce the treatment time compared with a conventional treatment. This radiation therapy is also called ablative stereotactic radiotherapy (SABR). The SBRT for the treatment of pulmonary sarcoma metastases can play an important role in the following circumstances: Inoperable metastases at critical sites; recurrent metastases; Inoperable patients due to limited lung function. And especially in metastasis of tumor types particularly resistant to the dose of radiotherapy used in previous SBRT techniques such as chordoma, chondrosarcoma, osteosarcoma, where, thanks to the development of SBRT, it is possible to deliver a higher biological dose. With this new technique, one can speak of providing excellent local control of pulmonary sarcoma metastases with an impact on survival in selected patients, without being invasive, very well tolerated and with minimal toxicity, mainly in those patients who for different reasons they cannot be offered metastasectomy. The aim of this paper is to review the scientific literature regarding the treatment of pulmonary metastases of sarcoma by SBRT. 

https://crimsonpublishers.com/nacs/fulltext/NACS.000522.php  


Novel Approaches in Cancer Study: Crimson Publishers
For more open access journals in crimson publishers please click on link: https://crimsonpublishers.com
For More Articles on Journal of Cancer Research Please click on: https://crimsonpublishers.com/nacs/
 

Comments

Post a Comment

Popular posts from this blog

Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme_Crimson Publishers

Image
  Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme by Siddharth Shah in  in Novel Approaches in Cancer Study Abstract Glioblastoma Multiforme (GBM, WHO grade IV) is one of the most aggressive, invasive, and lethal intracranial neoplasms, with a low post-diagnosis survival rate. Standard-of-care treatment regimens involving maximal surgical resection, radiotherapy, and genetic anti-tumor compounds like Temozolomide have only been marginally effective in improving overall survival and quality of life. Cell fusion, autophagy, and other complex biological processes affecting GBM pathophysiology are being studied to improve GBM treatment. This paper therefore focuses on oncolytic virus therapy combined with surgical resection, photodynamic therapy, and novel gene therapy, demonstrating how GBM treatment for patients could result in immediate and authentic tumor cytotoxicity and removal, rather than treatment of recurrent GBM. Standard therapy for GBM,...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases

Abstract Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tumor environment. Therefore, the purpose of this study is to correlate a possible contribution of the Pi release in the tumor microenvironment by ecto-nucleotidases and ecto-phosphatases, concomitant to the regulation of Pi extracellular pool by specific Pi...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases_Crimson Publishers

Image
Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases by Marco Antonio Lacerda-Abreu and José Roberto Meyer- Fernandes in Journal of Cancer Research Crimson Publishers _  Novel Approaches in Cancer Study Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tu...
Read more